Acadia Healthcare Co Q1 2024 Adj EPS $0.84 Beats $0.81 Estimate, Sales $768.051M Miss $779.166M Estimate
Portfolio Pulse from Benzinga Newsdesk
Acadia Healthcare Co (NASDAQ:ACHC) reported Q1 2024 adjusted EPS of $0.84, surpassing the $0.81 estimate, marking a 12% increase from the previous year. However, their sales of $768.051M fell short of the $779.166M estimate, despite being a 9.06% increase from the previous year.
May 01, 2024 | 8:26 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Acadia Healthcare reported a Q1 2024 adjusted EPS of $0.84, beating estimates, with a 12% YOY increase, but missed sales estimates with $768.051M, a 9.06% YOY increase.
The positive earnings beat by Acadia Healthcare is likely to be viewed favorably by investors, indicating operational efficiency and growth in profitability. However, the miss on sales estimates could temper enthusiasm, suggesting potential challenges in revenue growth or market expectations not being met. The mixed results present a neutral short-term impact as the positive earnings surprise may offset concerns over sales performance.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100